Argus lowered the firm’s price target on Integer (ITGR) to $152 from $160 and keeps a Buy rating on the shares. The firm cites the company’s ...

Argus Research analyst Steven Silver maintained a Buy rating on Integer Holdings (ITGR – Research Report) yesterday. The company’s shares ...

Full Year 2024 Results Key Financial Results Revenue: US$1.72b (up 7.5% from FY ...

Medical technology company Integer Holdings (NYSE:ITGR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up ...

Principal Financial Group Inc. lifted its stake in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) by 3.9% in the ...

Medical technology company Integer Holdings (NYSE:ITGR) will be announcing earnings results tomorrow before market hours.

Integer Holdings Corporation (NYSE: ITGR), a prominent manufacturer of medical devices, announced its financial performance for the fourth quarter and the full year that ended on December 31, 2024, on ...

O n Friday, KeyBanc Capital Markets analyst Brett Fishbin increased the price target for Integer Holdings Corporation (NYSE:ITGR) to $154.00, up from the previous target of $145.00. With the stock ...

The Plano, Texas-based company said it had profit of 90 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to $1.43 per share. The results missed Wall Street ...

Learn more about whether Integer Holdings Corporation or NovoCure Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Integer Holdings Corp (ITGR) reports robust sales growth and strategic acquisitions, despite facing challenges with tariffs and gross margins.